Amedisys Inc (AMED) Social Stream



Amedisys Inc (AMED): $91.07

0.11 (+0.12%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add AMED to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#14 of 66

in industry

AMEDISYS INC (AMED) Price Targets From Analysts

Use the tables below to see what analysts covering AMEDISYS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 13 $235 $150 $204.666 $93.62 118.61%
2021-12-07 13 $235 $150 $205.5 $93.62 119.5%
2021-12-21 14 $235 $150 $206.076 $93.62 120.12%
2022-01-06 14 $230 $150 $203.384 $93.62 117.24%
2022-01-20 14 $230 $150 $202.23 $93.62 116.01%
2022-02-01 14 $230 $145 $199.461 $93.62 113.05%
2022-02-02 14 $230 $145 $199.692 $93.62 113.3%
2022-02-17 14 $230 $147 $197.923 $93.62 111.41%
2022-02-25 15 $230 $147 $191.642 $93.62 104.7%
2022-03-01 15 $230 $147 $190.357 $93.62 103.33%
2022-03-08 15 $230 $147 $191.642 $93.62 104.7%
2022-03-24 15 $230 $160 $192.714 $93.62 105.85%
2022-04-01 15 $230 $162 $193 $93.62 106.15%
2022-04-29 15 $230 $131 $190.785 $93.62 103.79%
2022-05-03 15 $221 $131 $185.857 $93.62 98.52%
2022-05-26 15 $221 $131 $183.357 $93.62 95.85%
2022-05-27 15 $221 $117 $182.357 $93.62 94.78%
2022-06-13 15 $221 $117 $179.357 $93.62 91.58%
2022-06-21 15 $221 $107 $174.714 $93.62 86.62%
2022-07-14 16 $221 $102 $164.733 $93.62 75.96%
2022-07-29 16 $221 $102 $160.133 $93.62 71.05%
2022-08-01 16 $200 $102 $154.866 $93.62 65.42%
2022-08-02 16 $200 $102 $152.2 $93.62 62.57%
2022-08-03 16 $200 $95 $146.533 $93.62 56.52%
2022-09-06 16 $200 $95 $147.133 $93.62 57.16%
2022-09-19 16 $200 $95 $147.933 $93.62 58.01%
2022-10-03 16 $200 $95 $145.933 $93.62 55.88%
2022-10-05 16 $200 $95 $145.266 $93.62 55.17%
2022-10-19 16 $190 $95 $141.933 $93.62 51.61%
2022-10-25 16 $190 $95 $141.266 $93.62 50.89%
2022-10-27 16 $190 $90 $140.466 $93.62 50.04%
2022-10-28 16 $190 $90 $135.933 $93.62 45.2%
2022-11-02 16 $190 $90 $127.733 $93.62 36.44%
2022-11-03 16 $190 $90 $124.714 $93.62 33.21%
2022-11-11 16 $190 $90 $124.785 $93.62 33.29%
2022-12-05 16 $190 $90 $122.642 $93.62 31%
2023-01-03 16 $190 $84 $122.214 $93.62 30.54%
2023-01-17 16 $190 $84 $121.428 $93.62 29.7%
2023-01-19 16 $190 $84 $120 $93.62 28.18%
2023-02-15 16 $190 $84 $118.142 $93.62 26.19%
2023-02-21 16 $190 $84 $118.928 $93.62 27.03%
2023-02-22 16 $190 $84 $116.571 $93.62 24.52%
2023-02-24 16 $190 $84 $116 $93.62 23.91%
2023-03-10 15 $130 $84 $110.923 $93.62 18.48%
2023-03-29 15 $130 $84 $108.384 $93.62 15.77%
2023-04-13 15 $130 $84 $107.23 $93.62 14.54%
2023-04-21 15 $130 $84 $105.692 $93.62 12.89%
2023-05-05 14 $120 $84 $99.416 $93.62 6.19%
2023-05-09 14 $125 $81 $98 $93.62 4.68%
2023-06-06 14 $120 $81 $96.5 $93.62 3.08%
2023-06-26 13 $115 $84 $96.75 $93.62 3.34%
2023-06-27 13 $115 $84 $98.166 $93.62 4.86%
2023-07-03 13 $115 $84 $99 $93.62 5.75%
2023-07-28 13 $115 $84 $99.25 $93.62 6.01%
2023-07-31 13 $115 $84 $100.666 $93.62 7.53%
2023-08-01 13 $115 $84 $101 $93.62 7.88%
2023-08-02 13 $115 $84 $101.545 $93.62 8.47%
2023-08-21 12 $115 $84 $101.545 $93.62 8.47%
2023-09-13 12 $115 $84 $100.272 $93.62 7.11%
2023-11-21 13 $115 $73 $98.083 $93.62 4.77%
2023-12-29 13 $115 $73 $98.083 $93.62 4.77%

The Trend in the Analyst Price Target


Over the past 25 months, AMED's average price target has gone down $107.99.

Over the past 49 weeks, AMED's average upside potential has been 11.1%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-08-14 12 115 84 101.545 92.750 9.48%
2023-09-18 13 115 73 98.083 93.980 4.37%
2023-09-20 13 115 73 98.083 94.080 4.25%
2023-10-09 13 115 73 98.083 92.950 5.52%
2023-12-19 13 115 73 98.083 95.895 2.28%

AMED Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.77 2 1 9 1 1 13

The Trend in the Broker Recommendations


Over the past 43 months, AMED's average broker recommendation rating worsened by 1.06.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of stocks in the mid market cap category, AMEDISYS INC's number of analysts covering the stock is higher than 6546.92% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, AMEDISYS INC's average analyst price target is higher than 6457.49% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, AMEDISYS INC's upside potential (average analyst target price relative to current price) is greater than 3980.35% of them.
  • AMED has a lower variance in analysts' estimates than -3621.45% of Healthcare stocks.

In the Healthcare industry, CHE, AVAH, and FLGT are the three stocks most similar to AMEDISYS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding AMED using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!